Skip navigation
Skip navigation

Decreased levels of platelet-derived soluble glycoprotein VI detected prior to the first diagnosis of coronary artery disease in HIV-positive individuals

Gardiner, Elizabeth; Trevillyan, Janine M; Andrews, Robert; Maisa, Anna; Hearps, Anna C; Al-Tamimi, Mohammad; Crowe, Suzanne M; Hoy, Jennifer F

Description

HIV-positive patients are at increased risk for coronary artery disease (CAD); changes in platelet activation may play a role. This study was performed to determine if levels of soluble glycoprotein VI (sGPVI), a platelet-specific marker of activation, were different in HIV-positive patients compared with HIV-negative controls and further if levels were predictive of CAD in HIV. Twenty-four HIV-positive individuals (HIV cases) with CAD were compared with 46 age- and sex-matched HIV-positive...[Show more]

dc.contributor.authorGardiner, Elizabeth
dc.contributor.authorTrevillyan, Janine M
dc.contributor.authorAndrews, Robert
dc.contributor.authorMaisa, Anna
dc.contributor.authorHearps, Anna C
dc.contributor.authorAl-Tamimi, Mohammad
dc.contributor.authorCrowe, Suzanne M
dc.contributor.authorHoy, Jennifer F
dc.date.accessioned2021-06-03T23:16:53Z
dc.identifier.issn0953-7104
dc.identifier.urihttp://hdl.handle.net/1885/236743
dc.description.abstractHIV-positive patients are at increased risk for coronary artery disease (CAD); changes in platelet activation may play a role. This study was performed to determine if levels of soluble glycoprotein VI (sGPVI), a platelet-specific marker of activation, were different in HIV-positive patients compared with HIV-negative controls and further if levels were predictive of CAD in HIV. Twenty-four HIV-positive individuals (HIV cases) with CAD were compared with 46 age- and sex-matched HIV-positive controls without CAD and 41 HIV-negative controls (healthy controls). Platelet activation (represented by sGPVI level) was compared 12 months and 1 month prior to CAD diagnosis. sGPVI was quantified by ELISA. sGPVI levels were higher in HIV-positive subjects (combined) than healthy controls (122.5 ng/mL [interquartile ranges (IQR) 90.3–160.5] versus 84.7 ng/mL [IQR 48.6–119.5], p <0.001). Twelve months before the event, there was no difference in sGPVI between HIV cases and HIV controls (113.4 ng/mL [IQR 85.6–141.65] versus 128.0 ng/mL [IQR 96.6–179.4], p = 0.369). One month prior to the event, sGPVI was significantly lower in HIV cases compared with HIV controls (109.0 ng/mL [IQR 79.4–123.4] versus 133.9 ng/mL [IQR 112.7–171.9], p = 0.010). These results remained significant following adjustment for possible confounders. This work demonstrates that HIV infection is associated with higher sGPVI levels. A fall in sGPVI immediately prior to first coronary artery event may reflect a loss of negative-feedback mechanism and be an important pathological step in the development of symptomatic CAD, but further work is needed to confirm these findings and determine their clinical impact
dc.description.sponsorshipThis work was supported in part by the National Health and Medical Research Council of Australia and the National Heart Foundation. JMT was supported by an Australian Postgraduate Award. AM is supported by the Postdoctoral Programme of the German Academic Exchange Service (DAAD) and an Occupational Trainee Scholarship of the Burnet Institute
dc.format.mimetypeapplication/pdf
dc.language.isoen_AU
dc.publisherTaylor & Francis Group
dc.rights© 2016 Taylor & Francis Group, LLC..
dc.sourcePlatelets
dc.subjectHIV
dc.subjectCardiovascular disease
dc.subjectsoluble glycoprotein VI
dc.subjectThrombosis
dc.titleDecreased levels of platelet-derived soluble glycoprotein VI detected prior to the first diagnosis of coronary artery disease in HIV-positive individuals
dc.typeJournal article
local.description.notesImported from ARIES
local.identifier.citationvolume28
dc.date.issued2017
local.identifier.absfor060110 - Receptors and Membrane Biology
local.identifier.ariespublicationa383154xPUB5045
local.publisher.urlhttp://informahealthcare.com/journal/plt
local.type.statusPublished Version
local.contributor.affiliationGardiner, Elizabeth, College of Health and Medicine, ANU
local.contributor.affiliationTrevillyan, Janine M, Monash University
local.contributor.affiliationAndrews, Robert, Monash University
local.contributor.affiliationMaisa, Anna, Burnet Institute
local.contributor.affiliationHearps, Anna C, Burnet Institute
local.contributor.affiliationAl-Tamimi, Mohammad, Hashemite University
local.contributor.affiliationCrowe, Suzanne M, Burnet Institute
local.contributor.affiliationHoy, Jennifer F, Monash University
local.description.embargo2099-12-31
local.bibliographicCitation.issue3
local.bibliographicCitation.startpage301
local.bibliographicCitation.lastpage304
local.identifier.doi10.1080/09537104.2016.1237627
local.identifier.absseo970106 - Expanding Knowledge in the Biological Sciences
dc.date.updated2020-11-23T10:24:00Z
local.identifier.scopusID2-s2.0-84995475746
local.identifier.thomsonID000400794900014
CollectionsANU Research Publications

Download

File Description SizeFormat Image
01_Gardiner_Decreased_levels_of_2017.pdf716.6 kBAdobe PDF    Request a copy


Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  19 May 2020/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator